16 drug samples from Delhi govt hospitals failed dept test

Image
Press Trust of India New Delhi
Last Updated : Aug 31 2015 | 10:28 PM IST
Sixteen samples of drugs procured from ten government hospitals in the national capital did not pass the test of Delhi's Drug Control Department between April 2010 and March 2015, according to an RTI reply.
This information was given by the Drug Control Department of Delhi in reply to an Right To Information (RTI) query by activist Rajhans Bansal.
Drug samples for testing had been selected from medical stores at Sanjay Gandhi Hospital, Central Medical Store MCD Building (Civil Lines), Safdarjung Hospital, AIIMS, Shri Dada Dev Matri Avum Shishu Chikitsalaya (Dabri), Lok Nayak Hospital, GTB Hospital, Deen Dayal Upadhyay Hospital, Acharya Shree Bhikshu Hospital and Rao Tula Ram Memorial Hospital.
As per the information given by the department, anti-inflammatory drug Regunac and painkillers Diclofenac and Aspirin procured from Sanjay Gandhi Memorial Hospital in Mongolpuri, and Atenolol, to treat high blood pressure, and Aspirin from AIIMS failed to clear the test.
Anti-parasitic drug Albendazole procured from Lok Nayak Hospital and samples of cotton bandage roll from Safdarjung, GTB and Acharya Shree Bhikshu hospitals also failed the test.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 31 2015 | 10:28 PM IST

Next Story